share_log

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Raman-Tangella Vidya

SEC announcement ·  May 3 04:11
Summary by Futu AI
Teladoc Health's Chief Medical Officer, Raman-Tangella Vidya, engaged in stock transactions involving the company's common stock over two consecutive days. On May 1, 2024, Vidya acquired 10,244 shares through the exercise of derivative securities. The following day, Vidya sold 3,691 shares in the open market at a price of $12.688 per share, resulting in a total sale value of $46,831.41. After these transactions, Vidya's direct holdings in Teladoc Health amounted to 29,160 shares. The transactions are reported to be in progress.
Teladoc Health's Chief Medical Officer, Raman-Tangella Vidya, engaged in stock transactions involving the company's common stock over two consecutive days. On May 1, 2024, Vidya acquired 10,244 shares through the exercise of derivative securities. The following day, Vidya sold 3,691 shares in the open market at a price of $12.688 per share, resulting in a total sale value of $46,831.41. After these transactions, Vidya's direct holdings in Teladoc Health amounted to 29,160 shares. The transactions are reported to be in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.